Active · per the CBE, 29 September 2026

DR. REEKMANS

BE0877347974

Rechtspersoon Private limited company 1 establishment

Fooststraat 102, 1790 Affligem

Active for

20 year, 10 months

Financials

Financial year 2025

DR. REEKMANS from Affligem, company number BE0877347974, closed financial year 2025 with a result of € 85,878 after tax. For that financial year DR. REEKMANS recorded a gross margin of € 145,579 and equity of € 349,418. Compared with financial year 2024, the result moved from € 87,946 to € 85,878. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.

What it is worth Healthy

€ 349,418

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 85,878

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 309,559

▼ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 116,586 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 98,828

▲ 228% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 95,625 € 105,465 € 140,091 € 145,579 ▲ 4%
Profit after taxes € 48,852 € 63,738 € 87,946 € 85,878 ▼ 2%
Equity € 500,960 € 564,698 € 380,126 € 349,418 ▼ 8%
Total debts € 121,628 € 131,285 € 17,923 € 115,361 ▲ € 97,438
Cash € 544,973 € 630,692 € 339,103 € 309,559 ▼ 9%
Land & buildings - € 10,188 € 7,071 € 3,954 ▼ 44%
Retained profit € 488,560 € 552,298 € 367,726 € 337,018 ▼ 8%
Dividend € 0 € 0 € 272,518 € 116,586 ▼ 57%
Balance sheet total € 622,588 € 695,983 € 398,049 € 464,779 ▲ 17%

Key figures of DR. REEKMANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. REEKMANS?

What happened at DR. REEKMANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 85,878 (▼ 2% vs 2024). Source: NBB ↗
  • New establishment in Affligem. KBO
  • Start of the company according to the CBE. KBO

In short

From € 48,852 profit in 2022 to € 85,878 profit in 2025.

Paid € 121,351 in corporate taxes since 2022.

Best year ever: 2024, with € 87,946 profit.

Paid out € 389,104 in dividends to the owners in total.

Establishments

Establishment units

Physical locations of this company

Registered office

Fooststraat 102

1790 Affligem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0877.347.974
VAT number
BE 0877.347.974
Registered office
Fooststraat 102, 1790 Affligem
Names & denominations
DR. REEKMANS
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
18 November 2005
Peppol
Active · Active since 21 Jan 2026

Frequently asked questions

What is the address of DR. REEKMANS?
The registered office of DR. REEKMANS is located at Fooststraat 102, 1790 Affligem.
Is DR. REEKMANS still active?
Yes. According to the CBE (29 September 2026) DR. REEKMANS is active, legal situation “Normale toestand”, started on 18 November 2005.
Is DR. REEKMANS registered on Peppol?
Yes, DR. REEKMANS is registered on the Peppol network with ID 0208:0877347974.
What is the enterprise number of DR. REEKMANS?
The enterprise number of DR. REEKMANS is BE0877347974.
When was DR. REEKMANS founded?
DR. REEKMANS was founded on 18 November 2005.
Is DR. REEKMANS a reliable company?
Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 November 2005; 5 annual accounts filed, latest fiscal year 2025.